“Prospects for the Use of Two-Stage Therapy in Various Variants of Vaginal Microbiota Disorders”, Journal of Pharmaceutical Negative Results, pp. 2394–2399, Nov. 2022, doi: 10.47750/pnr.2022.13.S08.296.